Cargando…
The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies
In the last decades, progresses in medical oncology have ameliorated the treatment of patients and their outcome. However, further improvements are still necessary, in particular for certain types of tumors such as pancreatic, gastric, and lung cancer as well as acute myeloid leukemia where early de...
Autores principales: | Quirico, Lorena, Orso, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090592/ https://www.ncbi.nlm.nih.gov/pubmed/35582611 http://dx.doi.org/10.20517/cdr.2019.103 |
Ejemplares similares
-
Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer
por: Preethi, K. Auxzilia, et al.
Publicado: (2022) -
Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers
por: Takizawa, Satoko, et al.
Publicado: (2022) -
Exosomal MicroRNAs as Liquid Biopsy Biomarkers in Hepatocellular Carcinoma
por: Wang, Shuo, et al.
Publicado: (2020) -
MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment
por: Virga, Federico, et al.
Publicado: (2021) -
Overview of microRNAs as liquid biopsy biomarkers for colorectal cancer sub-type profiling and chemoresistance
por: Buhagiar, Alfred, et al.
Publicado: (2021)